Moderna falls after US FDA to hold expert panel meeting to review flu vaccine

Moderna

21/05/2026 16:14

** Shares of biotech Moderna MRNA.O fall 3% to $46.70 in morning trading

** The U.S. FDA says it will hold a meeting of outside experts to review MRNA's experimental flu shot

** Advisory committee meeting is scheduled for June 18

** FDA had
reversed course
 to review co's amended application for the mRNA-based seasonal flu vaccine after initially rejecting the submission

** Agency's decision is expected by August 5

** Including session's move, stock up 58.2% YTD

 (Reporting by Puyaan Singh)

 ((Puyaan.Singh@thomsonreuters.com;))